Your browser doesn't support javascript.
loading
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds.
Sever, Belgin; Türkes, Cüneyt; Altintop, Mehlika D; Demir, Yeliz; Akalin Çiftçi, Gülsen; Beydemir, Sükrü.
Affiliation
  • Sever B; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Türkes C; Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Turkey.
  • Altintop MD; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Demir Y; Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Turkey.
  • Akalin Çiftçi G; Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Beydemir S; Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
Arch Pharm (Weinheim) ; 354(12): e2100294, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34569655
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Thiazoles / Carbonic Anhydrase Inhibitors / Cholinesterase Inhibitors Limits: Animals / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Thiazoles / Carbonic Anhydrase Inhibitors / Cholinesterase Inhibitors Limits: Animals / Humans Language: En Year: 2021 Type: Article